Audience
Type
Conditions
Procedures
Other
Results
2 May 2022
Consensus Statements and Guidelines
This article is the second in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn’s disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn’s disease and an update of previous guidelines.
2 May 2022
Consensus Statements and Guidelines
Crohn’s disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in progressive bowel damage and disability.1 CD can affect individuals of any age, from children to the elderly,2,3 and may cause significant morbidity and impact on quality of life. Up to one-third of patients present with complicated behaviour [strictures, fistula, or abscesses] at diagnosis.4 Most patients over time will develop a complication, with roughly 50% of patients requiring surgery within 10 years of diagnosis.5–7 As the precise aetiology of CD remains unknown, a curative therapy is not yet available.8 Several agents are available for the medical treatment of CD. Medical agents include mesalazine [5-ASA], locally active steroids [such as budesonide], systemic steroids, thiopurines such as azathioprine [AZA] and mercaptopurine [MP], methotrexate [MTX], and biologic therapies (such as anti-tumour necrosis factor [TNF], anti-integrins, and anti-interleukin [IL] 12/23].
2 May 2022
Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time.
15 March 2022
Presentations, Videos & Papers
The first in a series of EGS webinars was held over Zoom on the evening of March 14th. Over 450 delegates had signed up for the event which, judging by feedback on social media, was well received. Mr Richard Guy, Chair of the EGS Committee, chaired an interactive discussion with 3 Consultant Colorectal Surgeon panel members who also sit on the EGS committee – Miss Sarah Duff, Mr Chris Macklin and Mr Benjamin Box. Osman Chaudhary, Dukes’ Club representative on the EGS Committee, collated questions from delegates and the webinar was made additionally interactive with the use of polling.
29 November 2021
Good Practice
Presentations, Videos & Papers
The aim of the webinar is to provide an educational resource for trainees who have had their endoscopy training significantly impacted on by the pandemic and practicing Surgical endoscopists who are interested in up-skilling and taking on roles in interventional endoscopy or screening. Improving the profile of surgical endoscopists and endoscopy training is one of ACPGBIs key strategic aims currently and the webinar series will go some way towards doing this.
29 November 2021
Good Practice
Presentations, Videos & Papers
The aim of the webinar is to provide an educational resource for trainees who have had their endoscopy training significantly impacted on by the pandemic and practicing Surgical endoscopists who are interested in up-skilling and taking on roles in interventional endoscopy or screening. Improving the profile of surgical endoscopists and endoscopy training is one of ACPGBIs key strategic aims currently and the webinar series will go some way towards doing this.
12 October 2021
Presentations, Videos & Papers
Advanced and recurrent rectal cancer
4 October 2021
Presentations, Videos & Papers
EDI
Why does EDI Matter to us?
Talks from members of the EDI Committee, Chair of EDI Taskforce and ACPGBI President
21 September 2021
Presentations, Videos & Papers
Session 1: Rectal Anatomy and Rectal Cancer Staging
with
Alison Corr, Consultant Radiologist St. Marks, London
Ian Jenkins and Mr. Ben Griffiths ACPGBI Advanced Malignancy Subcommittee,
Amy Lord
Jordan Fletcher, The Dukes Club
17 August 2021
Good Practice
Presentations, Videos & Papers
An Olympus Webinar